Vitamin D
Humans
Breast Neoplasms
/ metabolism
Female
Cholecalciferol
/ pharmacology
Middle Aged
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
/ metabolism
Macrophages
/ metabolism
Tumor-Associated Macrophages
/ metabolism
Calcitriol
/ pharmacology
Adult
Aged
Cell Differentiation
/ drug effects
Antigens, CD
/ metabolism
Biomarkers, Tumor
/ metabolism
Breast cancer
Calcitriol
Macrophages
TAMs
Vitamin D3
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
27 Sep 2024
27 Sep 2024
Historique:
received:
10
04
2024
accepted:
13
09
2024
medline:
28
9
2024
pubmed:
28
9
2024
entrez:
27
9
2024
Statut:
epublish
Résumé
Vitamin D
Identifiants
pubmed: 39333342
doi: 10.1038/s41598-024-73152-x
pii: 10.1038/s41598-024-73152-x
doi:
Substances chimiques
Cholecalciferol
1C6V77QF41
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
EC 1.14.15.18
Calcitriol
FXC9231JVH
CYP27B1 protein, human
EC 1.14.15.18
Antigens, CD
0
Biomarkers, Tumor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
22126Subventions
Organisme : Polish National Science Center
ID : 2017/27/B/NZ5/01167
Organisme : Polish National Science Center
ID : 2017/27/B/NZ5/01167
Organisme : Polish National Science Center
ID : 2017/27/B/NZ5/01167
Organisme : Polish National Science Center
ID : 2017/27/B/NZ5/01167
Organisme : Polish National Science Center
ID : 2017/27/B/NZ5/01167
Organisme : Polish National Science Center
ID : 2017/27/B/NZ5/01167
Organisme : Polish National Science Center
ID : 2017/27/B/NZ5/01167
Organisme : Polish National Science Center
ID : 2017/27/B/NZ5/01167
Informations de copyright
© 2024. The Author(s).
Références
Vanhevel, J., Verlinden, L., Doms, S., Wildiers, H. & Verstuyf, A. The role of Vitamin D in Breast cancer risk and progression. Endocrine-Relat. Cancer. https://doi.org/10.1530/ERC-21-0182 (2022).
doi: 10.1530/ERC-21-0182
Filip-Psurska, B., Zachary, H., Strzykalska, A., Wietrzyk, J. & Vitamin, D. Th17 lymphocytes, and breast cancer. Cancers (Basel)14, 3649. https://doi.org/10.3390/cancers14153649 (2022).
doi: 10.3390/cancers14153649
pubmed: 35954312
Eliassen, A. H. et al. Plasma 25-hydroxyvitamin D and risk of breast cancer in women followed over 20 years. Cancer Res.76, 5423–5430. https://doi.org/10.1158/0008-5472.CAN-16-0353 (2016).
doi: 10.1158/0008-5472.CAN-16-0353
pubmed: 27530324
pmcid: 5026605
Mohr, S. B., Gorham, E. D., Kim, J., Hofflich, H. & Garland, C. F. Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer. Anticancer Res.34, 1163–6 (2014).
pubmed: 24596354
Chen, P. et al. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res. Treat.121, 469–477. https://doi.org/10.1007/s10549-009-0593-9 (2010).
doi: 10.1007/s10549-009-0593-9
pubmed: 19851861
Vrieling, A. et al. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res.13, R74. https://doi.org/10.1186/BCR2920 (2011).
doi: 10.1186/BCR2920
pubmed: 21791049
pmcid: 3236338
Song, D. et al. Vitamin D intake, blood vitamin D levels, and the risk of breast cancer: a dose-response meta-analysis of observational studies. Aging (Albany NY)11, 12708–12732. https://doi.org/10.18632/AGING.102597 (2019).
doi: 10.18632/AGING.102597
pubmed: 31884419
Zhou, L., Chen, B., Sheng, L. & Turner, A. The effect of vitamin D supplementation on the risk of breast cancer: A trial sequential meta-analysis. Breast Cancer Res. Treat. https://doi.org/10.1007/S10549-020-05669-4 (2020).
doi: 10.1007/S10549-020-05669-4
pubmed: 33057995
pmcid: 7228827
Prentice, R. L. et al. Health risks and benefits from calcium and vitamin D supplementation: Women’s Health Initiative clinical trial and cohort study. Osteoporos Int.24, 567–580. https://doi.org/10.1007/s00198-012-2224-2 (2013).
doi: 10.1007/s00198-012-2224-2
pubmed: 23208074
Manson, J. A. E., Bassuk, S. S. & Buring, J. E. Principal results of the VITamin D and OmegA-3 TriaL (VITAL) and updated meta-analyses of relevant vitamin D trials. J. Steroid Biochem. Mol. Biol. https://doi.org/10.1016/J.JSBMB.2019.105522 (2020).
doi: 10.1016/J.JSBMB.2019.105522
pubmed: 31733345
Scragg, R. The vitamin D assessment (ViDA) study - design and main findings. J. Steroid Biochem. Mol. Biol. https://doi.org/10.1016/J.JSBMB.2019.105562 (2020).
doi: 10.1016/J.JSBMB.2019.105562
pubmed: 32360596
Virtanen, J. K. et al. Vitamin D supplementation and prevention of cardiovascular disease and cancer in the Finnish vitamin D trial: A randomized controlled trial. Am. J. Clin. Nutr.115, 1300–1310. https://doi.org/10.1093/AJCN/NQAB419 (2022).
doi: 10.1093/AJCN/NQAB419
pubmed: 34982819
pmcid: 9071497
Matilainen, J. M., Malinen, M., Turunen, M. M., Carlberg, C. & Väisänen, S. The number of vitamin D receptor binding sites defines the different vitamin D responsiveness of the CYP24 gene in malignant and normal mammary cells. J. Biol. Chem.285, 24174–83. https://doi.org/10.1074/jbc.M110.124073 (2010).
doi: 10.1074/jbc.M110.124073
pubmed: 20460683
pmcid: 2911343
Dennis, C. et al. Local production of active vitamin D3 metabolites in breast cancer cells by CYP24A1 and CYP27B1. J. Steroid Biochem. Mol. Biol.232, 106331. https://doi.org/10.1016/J.JSBMB.2023.106331 (2023).
doi: 10.1016/J.JSBMB.2023.106331
pubmed: 37244301
Lopes, N. et al. Alterations in vitamin D signalling and metabolic pathways in breast cancer progression: A study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions vitamin D pathways unbalanced in breast lesions. BMC Cancer10, 483. https://doi.org/10.1186/1471-2407-10-483 (2010).
doi: 10.1186/1471-2407-10-483
pubmed: 20831823
pmcid: 2945944
Welsh, J. Function of the vitamin D endocrine system in mammary gland and breast cancer. Mol. Cell Endocrinol.453, 88–95. https://doi.org/10.1016/j.mce.2017.04.026 (2017).
doi: 10.1016/j.mce.2017.04.026
pubmed: 28579119
pmcid: 5538720
Ditsch, N. et al. The association between vitamin D receptor expression and prolonged overall survival in breast cancer. J. Histochem. Cytochem.60, 121–129. https://doi.org/10.1369/0022155411429155 (2012).
doi: 10.1369/0022155411429155
pubmed: 22108646
pmcid: 3351121
Al-Azhri, J. et al. Tumor expression of vitamin D receptor and breast cancer histopathological characteristics and prognosis. Clin. Cancer Res.23, 97–103. https://doi.org/10.1158/1078-0432.CCR-16-0075 (2017).
doi: 10.1158/1078-0432.CCR-16-0075
pubmed: 27407090
Huss, L. et al. Vitamin D receptor expression in invasive breast tumors and breast cancer survival. Breast Cancer Res.21, 84. https://doi.org/10.1186/s13058-019-1169-1 (2019).
doi: 10.1186/s13058-019-1169-1
pubmed: 31358030
pmcid: 6664551
Zinser, G. M. & Welsch, J. E. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Carcinogenesis25, 2361–2372. https://doi.org/10.1093/CARCIN/BGH271 (2004).
doi: 10.1093/CARCIN/BGH271
pubmed: 15333467
Williams, J. D. et al. Tumor autonomous effects of vitamin D deficiency promote breast cancer metastasis. Endocrinology157, 1341–1347. https://doi.org/10.1210/en.2015-2036 (2016).
doi: 10.1210/en.2015-2036
pubmed: 26934299
pmcid: 4816742
Zhalehjoo, N., Shakiba, Y. & Panjehpour, M. Gene expression profiles of CYP24A1 and CYP27B1 in malignant and normal breast tissues. Mol. Med. Rep.15, 467–473. https://doi.org/10.3892/mmr.2016.5992 (2017).
doi: 10.3892/mmr.2016.5992
pubmed: 27922682
Li J, Luco AL, Ochietti B, Fadhil I, Camirand A, Reinhardt TA, et al. Tumoral vitamin D synthesis by CYP27B1 1-α-hydroxylase delays mammary tumor progression in the PyMT-MMTV mouse model and its action involves NF-κB modulation. Endocrinology. 2016;157: 2204–2216. doi: https://doi.org/10.1210/en.2015-1824
doi: 10.1210/en.2015-1824
pubmed: 27119753
Yang, L. & Zhang, Y. Tumor-associated macrophages: from basic research to clinical application. J. Hematol. Oncol.10, 58. https://doi.org/10.1186/S13045-017-0430-2 (2017).
doi: 10.1186/S13045-017-0430-2
pubmed: 28241846
pmcid: 5329931
Fu, L. Q. et al. The roles of tumor-associated macrophages in tumor angiogenesis and metastasis. Cell Immunol.353, 104119. https://doi.org/10.1016/J.CELLIMM.2020.104119 (2020).
doi: 10.1016/J.CELLIMM.2020.104119
pubmed: 32446032
Monkawa, T., Yoshida, T., Hayashi, M. & Saruta, T. Identification of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression in macrophages. Kidney Int.58, 559–568. https://doi.org/10.1046/J.1523-1755.2000.00202.X (2000).
doi: 10.1046/J.1523-1755.2000.00202.X
pubmed: 10916079
Esteban, L., Vidal, M. & Dusso, A. 1α-Hydroxylase transactivation by γ-interferon in murine macrophages requires enhanced C/EBPβ expression and activation. J. Steroid Biochem. Mol. Biol.89–90, 131–137. https://doi.org/10.1016/j.jsbmb.2004.03.092 (2004).
doi: 10.1016/j.jsbmb.2004.03.092
pubmed: 15225760
Nygaard, R. H. et al. Metabolism of 25-Hydroxy-vitamin D in human macrophages is highly dependent on macrophage polarization. Int. J. Mol. Sci.23, 10943. https://doi.org/10.3390/IJMS231810943/S1 (2022).
doi: 10.3390/IJMS231810943/S1
pubmed: 36142855
pmcid: 9505540
Anisiewicz, A., Łabędź, N., Krauze, I. & Wietrzyk, J. Calcitriol in the presence of conditioned media from metastatic breast cancer cells enhances Ex vivo polarization of M2 alternative murine bone marrow-derived macrophages. Cancers (Basel)12, 3485. https://doi.org/10.3390/cancers12113485 (2020).
doi: 10.3390/cancers12113485
pubmed: 33238581
Anisiewicz, A., Pawlik, A., Filip-Psurska, B. & Wietrzyk, J. Differential Impact of calcitriol and its analogs on tumor stroma in young and aged ovariectomized mice bearing 4T1 mammary gland cancer. Int. J. Mol. Sci.21, 6359. https://doi.org/10.3390/ijms21176359 (2020).
doi: 10.3390/ijms21176359
pubmed: 32887237
pmcid: 7503326
Anisiewicz, A. et al. Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer. Int. J. Oncol.52, 103–126. https://doi.org/10.3892/ijo.2017.4185 (2017).
doi: 10.3892/ijo.2017.4185
pubmed: 29115583
pmcid: 5743363
Anisiewicz, A. et al. Vitamin d metabolite profile in cholecalciferol-or calcitriol-supplemented healthy and mammary gland tumor-bearing mice. Nutrients12, 1–28. https://doi.org/10.3390/nu12113416 (2020).
doi: 10.3390/nu12113416
Stachowicz-Suhs, M. et al. Calcitriol promotes M2 polarization of tumor-associated macrophages in 4T1 mouse mammary gland cancer via the induction of proinflammatory cytokines. Sci. Rep.14, 3778. https://doi.org/10.1038/s41598-024-54433-x (2024).
doi: 10.1038/s41598-024-54433-x
pubmed: 38355711
pmcid: 10866890
Łabędź, N. et al. Dual effect of vitamin D3 on breast cancer-associated fibroblasts. BMC Cancer24, 209. https://doi.org/10.1186/s12885-024-11961-z (2024).
doi: 10.1186/s12885-024-11961-z
pubmed: 38360633
pmcid: 10868064
Lowry, O.H., Rosebrough, N.J., Farr, A.L., & Randall, R.J. Protein measurement with the folin phenol reagent.. J. Biol. Chem.193, 265–275. https://doi.org/10.1016/S0021-9258(19)52451-6 (1951).
doi: 10.1016/S0021-9258(19)52451-6
Peterson, G. L. Review of the Folin phenol protein quantitation method of Lowry, Rosebrough, Farr and Randall. Anal. Biochem.100, 201–220. https://doi.org/10.1016/0003-2697(79)90222-7 (1979).
doi: 10.1016/0003-2697(79)90222-7
pubmed: 393128
Wasnik, S. et al. 1,25-Dihydroxyvitamin D suppresses M1 macrophages and promotes M2 differentiation at bone injury sites. JCI Insight. https://doi.org/10.1172/JCI.INSIGHT.98773 (2018).
doi: 10.1172/JCI.INSIGHT.98773
pubmed: 30185660
pmcid: 6171806
Guo, Y. et al. Effect of 1α,25(OH)2D3-Treated M1 and M2 macrophages on cell proliferation and Migration ability in Ovarian Cancer. Nutr. Cancer74, 2632–2643. https://doi.org/10.1080/01635581.2021.2014903 (2022).
doi: 10.1080/01635581.2021.2014903
pubmed: 34894920
Du, L. et al. KDM6B regulates M2 polarization of macrophages by modulating the stability of nuclear β-catenin. Biochim. Biophys. Acta - Mol. Basis Dis.1869, 166611. https://doi.org/10.1016/J.BBADIS.2022.166611 (2023).
doi: 10.1016/J.BBADIS.2022.166611
pubmed: 36427698
Zhang, Y. et al. VDR status arbitrates the prometastatic effects of tumor-associated macrophages. Mol. Cancer Res.12, 1181–91. https://doi.org/10.1158/1541-7786.MCR-14-0036 (2014).
doi: 10.1158/1541-7786.MCR-14-0036
pubmed: 24821711
de Lyra, E.C., da Silva, I.A., Katayama, M.L.H., Brentani, M.M., Nonogaki, S., Góes, J.C.S, et al. 25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1α-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer. J. Steroid Biochem. Mol. Biol.100, 184–192 (2006).
Gunaydin, G. CAFs interacting with TAMs in tumor microenvironment to enhance tumorigenesis and immune evasion. Front. Oncol.11, 2669. https://doi.org/10.3389/FONC.2021.668349/BIBTEX (2021).
doi: 10.3389/FONC.2021.668349/BIBTEX
Roszer, T. Understanding the mysterious M2 macrophage through activation markers and effector mechanisms. Mediators Inflamm.2015, e816460. https://doi.org/10.1155/2015/816460 (2015).
doi: 10.1155/2015/816460
DeNardo, D. G. & Ruffell, B. Macrophages as regulators of tumor immunity and immunotherapy. Nat. Rev. Immunol.19, 369. https://doi.org/10.1038/S41577-019-0127-6 (2019).
doi: 10.1038/S41577-019-0127-6
pubmed: 30718830
pmcid: 7339861
Pan, Y., Yu, Y., Wang, X. & Zhang, T. Tumor-associated macrophages in tumor immunity. Front. Immunol. https://doi.org/10.3389/FIMMU.2020.583084 (2020).
doi: 10.3389/FIMMU.2020.583084
pubmed: 33692776
pmcid: 7780884
Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol.25, 677–686. https://doi.org/10.1016/J.IT.2004.09.015 (2004).
doi: 10.1016/J.IT.2004.09.015
pubmed: 15530839
Ambarus, C. A. et al. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J. Immunol. Methods375, 196–206. https://doi.org/10.1016/J.JIM.2011.10.013 (2012).
doi: 10.1016/J.JIM.2011.10.013
pubmed: 22075274
Miyasato, Y. et al. High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer. Cancer Sci.108, 1693–1700. https://doi.org/10.1111/CAS.13287 (2017).
doi: 10.1111/CAS.13287
pubmed: 28574667
pmcid: 5543503
Xiao, Y. et al. CD44-Mediated poor prognosis in glioma is Associated with M2-Polarization of Tumor-Associated macrophages and Immunosuppression. Front. Surg.8, 785. https://doi.org/10.3389/FSURG.2021.775194/BIBTEX (2022).
doi: 10.3389/FSURG.2021.775194/BIBTEX
Rhee, I. Diverse macrophages polarization in tumor microenvironment. Arch. Pharm. Res.39, 1588–1596. https://doi.org/10.1007/S12272-016-0820-Y (2016).
doi: 10.1007/S12272-016-0820-Y
pubmed: 27562774
Lawrence, T. & Natoli, G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol.11, 750–761. https://doi.org/10.1038/NRI3088 (2011).
doi: 10.1038/NRI3088
pubmed: 22025054
Kainulainen, K. et al. M1 macrophages induce protumor inflammation in melanoma cells through TNFR-NF-κB signaling. J. Invest. Dermatol.142, 3041-3051.e10. https://doi.org/10.1016/J.JID.2022.04.024 (2022).
doi: 10.1016/J.JID.2022.04.024
pubmed: 35580697
Tiainen S, Tumelius R, Rilla K, Hämäläinen K, Tammi M, Tammi R, et al. High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer. Histopathology. 2015;66: 873–883. doi: https://doi.org/10.1111/HIS.12607
doi: 10.1111/HIS.12607
pubmed: 25387851
Zhao, X., Qu, J., Sun, Y., Wang, J., Liu, X., & Wang, F., et al. Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature. Oncotarget. Impact J. 2017. https://doi.org/10.18632/oncotarget.15736
Klingen, T. A., Chen, Y., Aas, H., Wik, E. & Akslen, L. A. Tumor-associated macrophages are strongly related to vascular invasion, non-luminal subtypes, and interval breast cancer. Hum. Pathol.69, 72–80. https://doi.org/10.1016/J.HUMPATH.2017.09.001 (2017).
doi: 10.1016/J.HUMPATH.2017.09.001
pubmed: 28923419
Zhang, W. J. et al. Tumor-associated macrophages correlate with phenomenon of epithelial-mesenchymal transition and contribute to poor prognosis in triple-negative breast cancer patients. J. Surg. Res.222, 93–101. https://doi.org/10.1016/J.JSS.2017.09.035 (2018).
doi: 10.1016/J.JSS.2017.09.035
pubmed: 29273380
Moeenrezakhanlou, A., Nandan, D., Shephard, L. & Reiner, N. E. 1α,25-Dihydroxycholecalciferol activates binding of CREB to a CRE site in the CD14 promoter and drives promoter activity in a phosphatidylinositol-3 kinase-dependent manner. J. Leukoc Biol.81, 1311–1321. https://doi.org/10.1189/jlb.1106681 (2007).
doi: 10.1189/jlb.1106681
pubmed: 17327484
Moeenrezakhanlou, A., Shephard, L., Lam, L. & Reiner, N. E. Myeloid cell differentiation in response to calcitriol for expression CD11b and CD14 is regulated by myeloid zinc finger-1 protein downstream of phosphatidylinositol 3-kinase. J. Leukoc Biol.84, 519–528. https://doi.org/10.1189/jlb.1207833 (2008).
doi: 10.1189/jlb.1207833
pubmed: 18495781
Longtine, M. S. et al. Calcitriol regulates immune genes CD14 and CD180 to modulate LPS responses in human trophoblasts. Reproduction154, 735–744. https://doi.org/10.1530/REP-17-0183 (2017).
doi: 10.1530/REP-17-0183
pubmed: 29089453
Koli, K. & Keski-Oja, J. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells. Cancer Res.55, 1540–6 (1995).
pubmed: 7882362
Bajbouj, K. et al. Vitamin D exerts significant Antitumor effects by suppressing vasculogenic mimicry in breast cancer cells. Front. Oncol.12, 918340. https://doi.org/10.3389/FONC.2022.918340/BIBTEX (2022).
doi: 10.3389/FONC.2022.918340/BIBTEX
pubmed: 35747793
pmcid: 9210804
Pawlik, A. et al. Calcitriol and its analogs establish the Immunosuppressive Microenvironment that drives metastasis in 4T1 mouse mammary gland Cancer. Int. J. Mol. Sci.19, 2116. https://doi.org/10.3390/IJMS19072116 (2018).
doi: 10.3390/IJMS19072116
pubmed: 30037009
pmcid: 6073894
Gratchev, A. TGF-β signalling in tumour associated macrophages. Immunobiology222, 75–81. https://doi.org/10.1016/J.IMBIO.2015.11.016 (2017).
doi: 10.1016/J.IMBIO.2015.11.016
pubmed: 26876591
Zhang, F. et al. TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype. Oncotarget.7, 52294–52306. https://doi.org/10.18632/ONCOTARGET.10561 (2016).
doi: 10.18632/ONCOTARGET.10561
pubmed: 27418133
pmcid: 5239552
Chang, P. L., Ridall, A. L. & Prince, C. W. Calcitriol regulation of osteopontin expression in mouse epidermal cells. Endocrinology135, 863–9. https://doi.org/10.1210/endo.135.3.8070379 (1994).
doi: 10.1210/endo.135.3.8070379
pubmed: 8070379
Yan, Z., Hu, X., Tang, B. & Deng, F. Role of osteopontin in cancer development and treatment. Heliyon9, e21055. https://doi.org/10.1016/J.HELIYON.2023.E21055 (2023).
doi: 10.1016/J.HELIYON.2023.E21055
pubmed: 37867833
pmcid: 10587537
Icer, M. A. & Gezmen-Karadag, M. The multiple functions and mechanisms of osteopontin. Clin. Biochem.59, 17–24. https://doi.org/10.1016/J.CLINBIOCHEM.2018.07.003 (2018).
doi: 10.1016/J.CLINBIOCHEM.2018.07.003
pubmed: 30003880
So, J. Y. et al. A novel gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer. Mol. Pharmacol.79, 360–367. https://doi.org/10.1124/mol.110.068403 (2011).
doi: 10.1124/mol.110.068403
pubmed: 21115634
pmcid: 3061370
Imrich, S., Hachmeister, M. & Gires, O. EpCAM and its potential role in tumor-initiating cells. Cell Adh. Migr.6, 30–38. https://doi.org/10.4161/CAM.18953 (2012).
doi: 10.4161/CAM.18953
pubmed: 22647938
pmcid: 3364135
Spizzo, G. et al. High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer. Breast Cancer Res. Treat.86, 207–213. https://doi.org/10.1023/B:BREA.0000036787.59816.01 (2004).
doi: 10.1023/B:BREA.0000036787.59816.01
pubmed: 15567937
Benko, G., Spajić, B., Krušlin, B. & Tomas, D. Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer. Urol. Oncol.31, 468–474. https://doi.org/10.1016/J.UROLONC.2011.03.007 (2013).
doi: 10.1016/J.UROLONC.2011.03.007
pubmed: 21514185
Spizzo, G. et al. Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer. Gynecol. Oncol.103, 483–488. https://doi.org/10.1016/J.YGYNO.2006.03.035 (2006).
doi: 10.1016/J.YGYNO.2006.03.035
pubmed: 16678891
Eslami, -S. Z., Cortés-Hernández, L. E. & Alix-Panabières, C. Epithelial cell adhesion molecule: An anchor to isolate clinically relevant circulating tumor cells. Cells9, 1–17. https://doi.org/10.3390/CELLS9081836 (2020).
doi: 10.3390/CELLS9081836
Liu, Y. et al. Understanding the versatile roles and applications of EpCAM in cancers: From bench to bedside. Exp. Hematol. Oncol. https://doi.org/10.1186/S40164-022-00352-4 (2022).
doi: 10.1186/S40164-022-00352-4
pubmed: 36536374
pmcid: 9764574
Xie, J. et al. Yes-associated protein regulates the hepatoprotective effect of vitamin D receptor activation through promoting adaptive bile duct remodeling in cholestatic mice. J. Pathol.255, 95–106. https://doi.org/10.1002/PATH.5750 (2021).
doi: 10.1002/PATH.5750
pubmed: 34156701
Lu, J., Liang, T., Li, P. & Yin, Q. Regulatory effects of IRF4 on immune cells in the tumor microenvironment. Front. Immunol. https://doi.org/10.3389/FIMMU.2023.1086803 (2023).
doi: 10.3389/FIMMU.2023.1086803
pubmed: 38327764
pmcid: 10770832
Zhu, X. et al. 1,25–Dihydroxyvitamin D regulates macrophage polarization and ameliorates experimental inflammatory bowel disease by suppressing miR-125b. Int. Immunopharmacol.67, 106–118. https://doi.org/10.1016/J.INTIMP.2018.12.015 (2019).
doi: 10.1016/J.INTIMP.2018.12.015
pubmed: 30540970
Gauzzi, M. C. et al. IRF-4 expression in the human myeloid lineage: up-regulation during dendritic cell differentiation and inhibition by 1alpha,25-dihydroxyvitamin D3. J. Leukoc Biol.77, 944–947. https://doi.org/10.1189/JLB.0205090 (2005).
doi: 10.1189/JLB.0205090
pubmed: 15829558
Carreras E, Turner S, Frank MB, Knowlton N, Osban J, Centola M, et al. Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4. Blood. 2010;115: 238–246. doi: https://doi.org/10.1182/blood-2009-08-236935
doi: 10.1182/blood-2009-08-236935
pubmed: 19880499
pmcid: 2808152
Denger, S. et al. Transcriptome profiling of estrogen-regulated genes in human primary osteoblasts reveals an osteoblast-specific regulation of the insulin-like growth factor binding protein 4 Gene. Mol. Endocrinol.22, 361–379. https://doi.org/10.1210/me.2007-0292 (2008).
doi: 10.1210/me.2007-0292
pubmed: 17962383
pmcid: 5419644
Yang, J., Zhang, L., Yu, C., Yang, X.-F. & Wang, H. Monocyte and macrophage differentiation: Circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark. Res.2, 1. https://doi.org/10.1186/2050-7771-2-1 (2014).
doi: 10.1186/2050-7771-2-1
pubmed: 24398220
pmcid: 3892095
Bauer, S. R., Hankinson, S. E., Bertone-Johnson, E. R. & Ding, E. L. Plasma vitamin d levels, menopause, and risk of breast cancer:dose-response meta-analysis of prospective studies. Med. (United States)92, 123–131. https://doi.org/10.1097/MD.0b013e3182943bc2 (2013).
doi: 10.1097/MD.0b013e3182943bc2
O’Brien, K. M., Sandler, D. P., Taylor, J. A. & Weinberg, C. R. Serum vitamin D and risk of breast cancer within five years. Environ. Health Perspect. https://doi.org/10.1289/EHP943 (2017).
doi: 10.1289/EHP943
pubmed: 28728134
pmcid: 5744694
Xu, S. et al. Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing Smad2/3-, STAT3- and β-catenin-mediated epithelial-mesenchymal transition. Cancer Sci.111, 59–71. https://doi.org/10.1111/CAS.14237 (2020).
doi: 10.1111/CAS.14237
pubmed: 31729097
pmcid: 6942435
Xing, W. Y. et al. Calcitriol inhibits lipopolysaccharide-induced proliferation, migration and invasion of prostate cancer cells through suppressing STAT3 signal activation. Int. Immunopharmacol.82, 106346. https://doi.org/10.1016/J.INTIMP.2020.106346 (2020).
doi: 10.1016/J.INTIMP.2020.106346
pubmed: 32120344
Łabędź, N. et al. Modulation of fibroblast activity via vitamin D3 is dependent on tumor type—studies on mouse mammary gland cancer. Cancers (Basel)14, 4585. https://doi.org/10.3390/cancers14194585 (2022).
doi: 10.3390/cancers14194585
pubmed: 36230508
Mego, M. et al. Vitamin D and circulating tumor cells in primary breast cancer. Front. Oncol. https://doi.org/10.3389/FONC.2022.950451/FULL (2022).
doi: 10.3389/FONC.2022.950451/FULL
pubmed: 36505811
pmcid: 9730887